Ionizing radiation biomarkers in epidemiological studies - an update.
Authors
Hall, JJeggo, P
West, Catharine M L
Gomolka, M
Quintens, R
Badie, C
Laurent, O
Aerts, A
Anastasov, N
Azimzadeh, O
Azizova, T
Baatout, S
Baselet, B
Benotmane, M
Blanchardon, E
Guéguen, Y
Haghdoost, S
Harms-Ringhdahl, M
Hess, J
Kreuzer, M
Laurier, D
Macaeva, E
Manning, G
Pernot, E
Ravanat, J
Sabatier, L
Tack, K
Tapio, S
Zitzelsberger, H
Cardis, E
Affiliation
Centre de Recherche en Cancerologie de Lyon, INSERM 1052, CNRS 5286, Univ Lyon, Universite Claude Bernard, Lyon 1, Lyon, F-69424, FranceIssue Date
2017
Metadata
Show full item recordAbstract
Recent epidemiology studies highlighted the detrimental health effects of exposure to low dose and low dose rate ionizing radiation (IR): nuclear industry workers studies have shown increased leukaemia and solid tumour risks following cumulative doses of <100mSv and dose rates of <10mGy per year; paediatric patients studies have reported increased leukaemia and brain tumours risks after doses of 30-60mGy from computed tomography scans. Questions arise, however, about the impact of even lower doses and dose rates where classical epidemiological studies have limited power but where subsets within the large cohorts are expected to have an increased risk. Further progress requires integration of biomarkers or bioassays of individual exposure, effects and susceptibility to IR. The European DoReMi (Low Dose Research towards Multidisciplinary Integration) consortium previously reviewed biomarkers for potential use in IR epidemiological studies. Given the increased mechanistic understanding of responses to low dose radiation the current review provides an update covering technical advances and recent studies. A key issue identified is deciding which biomarkers to progress. A roadmap is provided for biomarker development from discovery to implementation and used to summarise the current status of proposed biomarkers for epidemiological studies. Most potential biomarkers remain at the discovery stage and for some there is sufficient evidence that further development is not warranted. One biomarker identified in the final stages of development and as a priority for further research is radiation specific mRNA transcript profiles.Citation
Ionizing radiation biomarkers in epidemiological studies - an update. 2017, 771:59-84 Mutat ResJournal
Mutation ResearchDOI
10.1016/j.mrrev.2017.01.001PubMed ID
28342453Type
ArticleLanguage
enISSN
1873-135Xae974a485f413a2113503eed53cd6c53
10.1016/j.mrrev.2017.01.001
Scopus Count
Collections
Related articles
- Ionizing radiation biomarkers for potential use in epidemiological studies.
- Authors: Pernot E, Hall J, Baatout S, Benotmane MA, Blanchardon E, Bouffler S, El Saghire H, Gomolka M, Guertler A, Harms-Ringdahl M, Jeggo P, Kreuzer M, Laurier D, Lindholm C, Mkacher R, Quintens R, Rothkamm K, Sabatier L, Tapio S, de Vathaire F, Cardis E
- Issue date: 2012 Oct-Dec
- Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study.
- Authors: Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Sir Craft AW, Parker L, Berrington de González A
- Issue date: 2012 Aug 4
- Low-dose ionising radiation and cardiovascular diseases--Strategies for molecular epidemiological studies in Europe.
- Authors: Kreuzer M, Auvinen A, Cardis E, Hall J, Jourdain JR, Laurier D, Little MP, Peters A, Raj K, Russell NS, Tapio S, Zhang W, Gomolka M
- Issue date: 2015 Apr-Jun
- Progress in low dose health risk research: Novel effects and new concepts in low dose radiobiology.
- Authors: Averbeck D, Salomaa S, Bouffler S, Ottolenghi A, Smyth V, Sabatier L
- Issue date: 2018 Apr-Jun
- Neurodevelopmental effects of low dose ionizing radiation exposure: A systematic review of the epidemiological evidence.
- Authors: Pasqual E, Bosch de Basea M, López-Vicente M, Thierry-Chef I, Cardis E
- Issue date: 2020 Mar